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Abstract 
Linda Rose Frank PhD, MSN, ACRN, FAAN 
United States Military STI Screening: 
Policy Analysis and Implications 
Nefertiti Monai Wade, MPH 
University of Pittsburgh, 2019 
ABSTRACT 
Problem: Serving in the United States armed forces can often expose individuals to high stress 
situations, which has been shown to negatively impact decision making. Increased high risk 
sexual behaviors, is one of the manifestations reported that may result in the acquisition of a 
sexually transmitted infections (STIs). Undetected STIs within a highly mobile military 
population poses a significant public health concern, which threatens military readiness. U.S. 
armed forces screening policies have the potential to influence the incidences of STIs/HIV 
within the military population and surrounding communities.  
Methods: United States Department of Defense, Air Force, Army, Navy and Marine Corps 
STI/HIV screening policies and prevention programs were examined. Population specific 
considerations were gathered from a literature search conducted through PubMed, Medical 
Surveillance Monthly Report and Military Medicine (Oxford’s International Journal of 
AMSUS). Limitations identified in current policies and population specific characteristics guided 
the development of screening recommendations, which are provided in a programmatic 
framework. 
Results: In alignment with medical advances and the simplification of STI treatment, the U.S. 
military has significantly reduced transmission of STIs within service members. Nevertheless, 
STIs continue to be the among the highest reported communicable diseases within the armed 
v 
forces. The incidence rates have increased in the recent years. The allowance of fluidity among 
STI screening policies may not adequately reduce the spread of STIs. 
Conclusions: Standardized screenings and health education could increase the detection of 
asymptomatic STIs, reducing the spread of infections within the military population.  
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1.0 Introduction 
This essay will present a policy and program analysis, which aims to (1) examine 
sexually transmitted infection (STI) screening policies mandated by the U.S. armed forces, (2) 
discuss the intersection of policies and population specific considerations regarding their 
possible impacts on the spread of STIs and (3) provide recommendations geared towards 
reducing transmission within the military population. 
STIs threaten U.S. military readiness due to frequent global mobility and high rates of 
infections found within the population. Undetected STIs  may results in increased vulnerability 
to Human Immunodeficiency Virus (HIV), pelvic inflammatory disease, ectopic pregnancy, 
infertility, cervical cancer and epididymitis lymphogranuloma venereum [3]. This essay will 
focus on HIV and bacterial STIs, including Chlamydia trachomatis (chlamydia), 
Neisseria gonorrhoeae (gonorrhea) and Treponema pallidum (syphilis). The STIs mentioned are 
classified as Armed Forces Reportable Medical Events, which are defined as significant threats 
to military operations due to transmission risks in the population, and having potential to disrupt 
trainings and deployments [4].   
As outlined below in Figure 1, this essay will examine the limitations and opportunities 
of screening policies, educational programming, population-specific considerations and reporting 
tools. This process will provide a clarified understanding of measures that are being taken to 
prevent and detect STIs in the military population, and guide the development of supplementary 
measures. Understanding the true burden of disease and frequency at which they occur will 
highlight the U.S. military community’s unique needs, regarding prevention programming and 
detection strategies. In alignment with the Department of Defense (DoD) mission of maximizing 
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mission readiness through the capacity of rapid mobility of personnel, it is imperative to 
prioritize the health of service members by preventing and detecting STIs.  
 
Figure 1 Mechanisms of undestanding and reducing STIs/HIV in the military 
1.1 Historical Overview 
Historically, the U.S. armed forces have always had a primary interest in preventing the 
spread of STIs. Various implemented measures by the U.S. armed forces had a common goal, 
which was to reduce the rate of STIs found within its’ population through varying approaches [5, 
6].  Withholding pay and member funded STI treatment during the Revolutionary War era, are 
early illustrations of applied control measures [5]. Advancements in modern medicine 
has strongly influenced policies, screening procedures, treatments and recovery time. As 
Goal: Reduce
STIs in the 
U.S. Armed 
Forces
Screening
Policies
Educational 
Programming
Limitations and 
Opportunities
Population
Considerations/
Characteristics
Reporting Tools  
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treatment became more effective and readily available, preventative measures have reduced 
significantly within the U.S. military.  
Gonorrhea and syphilis were the primary cause for enlistment rejection during pre-
accession screening in World War I (WWI) and World War II (WWII) [5]. In response to the 
high rate of observed infections, several prevention strategies were launched [6]. During WWI, 
General Order Number 215 sought to influence service members to abstain from high-risk sexual 
behaviors while deployed [5]. This method consisted of prolonging a member’s deployment, 
following an STI diagnosis during out-processing [5]. President Woodrow Wilson and The 
Commission on Training Camp Activities, implemented a social hygiene campaign during 
WWII, which promoted a high moral code in and around military installations [6]. This included 
the May Act, which banned supporting or engaging in prostitution near military installations [6, 
7]. Social hygiene campaigns placed an emphasis on risk reduction by promoting avoidance of 
pre-martial sexual intercourse, abstinence, prophylaxis and condom usage [5, 6]. Nevertheless, 
the above-mentioned strategies were unsuccessful at decreasing the spread of STIs within the 
military population [6, 8]. 
During WWII, Army researchers demonstrated 99.6% efficacy in sulfathiazole’s 
capability to prevent venereal diseases (syphilis, gonorrhea and chancroid) when used as a post 
exposure prophylaxis [6, 9, 10]. Following this development, resources areas referred to as “Pro-
stations”, were made accessible to service members [10]. Pro-stations were areas in which 
military personnel could visit to obtain condoms and prophylaxis kits containing an ointment 
mixture of 30% calomel and 15% sulfathiazole [10]. Although highly efficacious, post-exposure 
prophylaxis use of sulfathiazole only prevented 55% of infections when utilized by service 
members [6]. Poor sanitation, human behavior and logistical inadequacies led to lower than 
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anticipated prophylactic success rates within the U.S. armed forces [6, 10]. Nearing the end of 
the WWII, a large-scale trial conducted by the Army, demonstrated the effectiveness of 
penicillin use for gonorrhea treatment and reduced recovery time from an average of 38-50 days 
to 6.4 [9, 11]. 
The spread of STIs remained persistent within the military, despite the development of 
more effective treatments [6, 10, 11]. Within five years following WWII, STI rates doubled and 
continued to rise [8]. Gonorrhea rates were reported at 300 cases per 1,000 person-years, during 
the Vietnam War [9]. High-risk behaviors, such as sexual engagement with sex workers, were 
reported in deployed locations [8]. However, unsuccessful outcomes associated with WWII’s 
social hygiene campaigns, discouraged military leaders from implementing similar approaches 
during the Vietnam War [8,10]. Alternatively, the primary prevention strategy focused on 
education [8]. Policy outlined control measures during the Vietnam War, which included three 
prevention education encounters in deployed settings [8]. There were major shortfalls fulfilling 
the intended reach of the educational policy, as most personnel did not receive the required 
sessions [8]. STIs have remained prevalent within the U.S. military.  
The emergence of HIV in military personnel occurred in unison with the civilian 
population in the continental U.S. [12, 13]. In response to the epidemic, the DoD employed 
countermeasures, which included the authorization of routine HIV testing and the formation of 
the U.S. Military HIV Research Program (MHRP) [12, 13]. Studies conducted within the MHRP 
provided evidence supporting heterosexual HIV transmission and examined the natural history of 
seroconversion [9]. Presently, the U.S. military continues to contribute towards the eradication of 
HIV, through ongoing vaccine research and standardized personnel screening [9].   
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1.2 Current U.S. Military Demographics 
Approximately 2,109,300 military personnel serve in the Air Force, Army, Navy and 
Marine Corps — males representing the largest proportion at 83.8% and female representing 
16.2% of the total armed forces [14]. Eighteen to 25-year-olds represent approximately 51.7% of 
the active duty U.S. military population and 90% of accessed members [4].   
Data in graph derived from 2017 Demographic Report [15] 
Figure 2 U.S. Armed Forces Age Demographics 
by service branch, 2017 
Lesbian, gay, bisexual and transgender (LGBT) service members represent 6.1% of U.S. 
military personnel [16]. However, prior research suggests that the true population of men who 
have sex with (MSM) within the military is higher than reported self-identifying figures [1, 15]. 
Table 1. Percentage of LGBT U.S. 
Military Personnel, 2015 
Total  6.1% 
Male  4.2% 
6 
Female 16.6% 
Ages 17-24 9.30% 
Ages 25-34 6.40% 
Ages 35-44 2.60% 
Ages ≥45 2.80% 
2015 Department of Defense Health Related Behavior Survey [16] 
1.3 U.S. Military and General U.S. Populace STI Incidence Rates 
Fifteen to 24-year-olds account for 50% of all newly reported STI cases in the United 
States [17]. Approximately 50% of those serving in U.S. armed forces fall within the 18-24-year-
old age demographic [14, 17]. The military follows a similar age and gender distribution of 
newly diagnosed STIs when compared to the civilian population (see Appendix A).  
The CDC has noted an overall 22% increase of chlamydia infections since 2013 [17]. As 
reflected in Figures 3 and 4, there is a paralleled increase of reported chlamydia infections within 
the U.S. population and armed forces, with the strongest correlations existing among women 
between the ages of 20-24 (see Appendix A) [2, 17, 18]. Surveillance bias likely affects the 
reported incidence rates for STIs, as females receive screenings at a higher frequency than males 
[17-19]. 
According to the CDC, reported gonorrhea rates have increased by 67% among the 
general population [17]. As reflected in Figure 6, there is a noticeable increasing trend, most 
significantly among men in the U.S. [17]. However, females receive gonorrhea diagnoses more 
frequently than males in the U.S. armed forces [2, 17]. Surveillance bias noted within the 
military could be an explanatory cause of the contradictory trend [19]. Nevertheless, the CDC 
Table 1 Continued
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estimates the true gonorrhea incidences within the general population is two times the reported 
rate, due to low screening frequencies [17]. 
As reflected in Figures 7 and 8, reported primary and secondary syphilis has increased by 
76% since 2013 [2, 17]. MSM are most frequently diagnosed with syphilis in both populations 
[2, 17]. Newly diagnosed cases of HIV occur at a lower rate in the U.S. armed forces than in the 
U.S. population [1, 20]. From 2010-2016, the DoD averaged 25 new HIV diagnoses per 100,000 
members tested [20].  
Figure 3 Incidence rate of chlamydia infections, military 
(by sex, U.S. armed forces- active duty 2010-2018) [2] 
Graph obtained from Stahlman and Oetting, 20191 
Figure 4 Incidence rate of chlamydia infections, U.S. 
(by sex, 2010-2017) [1] 
Data within graph derived from CDC2 
1 Data in graphs referencing military incidence rates were obtained from 2.Stahlman, S. and A.A. Oetting, Sexually 
transmitted infections, active component, U.S. Armed Forces, 2010-2018. MSMR, 2019. 26(3): p. 2-10. 
2 Data in graphs, which reference U.S. population incidence rates obtained from the following source 17.Sexually 
Transmitted Disease Surveillance 2017. 2018, Centers for Disease Control and Prevention, Division of STD 
Prevention. 
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Figure 5 Incidence rate of gonorrhea infections, military    
(by sex, U.S. armed forces- active duty 2010-2018) [2] 
Graph obtained from Stahlman and Oetting, 20193 
Figure 6 Incidence rate of gonorrhea infections, U.S. 
(by sex, 2010-2017) [1]     
Data within derived from CDC4   
Figure 7 Incidence rate of syphilis infections, military   
(by sex, U.S. armed forces- active duty 2010-2018) [2]             
    Graph obtained from Stahlman and Oetting, 20193 
Figure 8 Incidence rate of syphilis infections, U.S. 
(by sex, 2010-2017) [1]     
Data within graph derived from CDC4 
3 Data in graphs referencing military incidence rates were obtained from 2.Stahlman, S. and A.A. Oetting, Sexually 
transmitted infections, active component, U.S. Armed Forces, 2010-2018. MSMR, 2019. 26(3): p. 2-10. 
4 Data in graphs, which reference U.S. population incidence rates obtained from the following source 17.Sexually 
Transmitted Disease Surveillance 2017. 2018, Centers for Disease Control and Prevention, Division of STD 
Prevention. 
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2.0 Methods 
DoD doctrine databases were searched for STI and HIV military screening regulations. 
Databases included the Executive Services Directorate, Air Force E-Publishing, Army 
Publishing Directorate, the Navy Personnel Command and official military websites [21-24]. 
Available Memorandums for Record were included, if pertinent to mandatory prevention 
programs or screening policies [23, 25]. Screening and program inclusion criteria consisted of 
the explicit requirement of the particular item within current policy or confirmation from military 
medical personnel. A small number of inconsistencies regarding STI screening standards and 
programs were identified between policies and information listed on governmental websites. 
These inconsistencies were assessed through key informant interviews with military medical 
personnel and included if suitable [24, 26]. 
Population specific considerations were assessed through various methods. The 2015 
Department of Defense Health Related Behavior Survey provided military specific risk 
information [16]. A literature search was conducted through PubMed and Military Medicine 
(Oxford’s International Journal of AMSUS), which utilized a combination of search terms and 
phases. Terminology and phrases included United States military, STIs, asymptomatic infections, 
extragenital STIs, chlamydia, gonorrhea, HIV, high-risk sexual behaviors, prevention 
programming, routine and cost-effectiveness of STI screening. Additionally, the index of the 
Medical Surveillance Monthly Report was examined and articles were reviewed based on 
relevancy determined by article titles. Title relevancy included the mention of STIs, HIV, 
chlamydia, gonorrhea, surveillance, reporting and secondary STI related conditions [27]. 
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Information from these sources were considered for inclusion based upon military screening 
implications.  
Recommended screening frequencies were obtained from the Centers of Disease Control 
and Prevention (CDC) and United States Preventative Services Task Force (USPSTF) [28, 29]. 
U.S. population incidence rates were obtained from the 2017 Sexually Transmitted Disease 
Surveillance report published by the CDC [1, 17].  Data in the report derived from state health 
departments, whom are required to report all laboratory confirmed cases of chlamydia, 
gonorrhea, syphilis (primary and secondary cases) and HIV to the CDC’s National Notifiable 
Diseases Surveillance System [1, 17]. Air Force, Army, Navy and Marine Corps STI incidence 
rates were collected from articles published in the Medical Surveillance Monthly Report, 
“Sexually Transmitted Infections, Active Component, U.S. Armed Forces, 2006-2017 and 2010-
2018” [2, 18]. Reported military incidents originated from administrative health data, reported 
medical events to the Armed Forces Health Surveillance Branch and medical encounters 
documented in the Medical Data Store [2].  
This essay will analyze DoD, United States Air Force, Department of the Army and 
Department of the Navy (Navy and Marine Corps) STI and HIV screening polices. The essay 
will identify military policies, specific characteristics and issues of the military population, and 
provide programmatic recommendations aimed to reduce transmission of STIs and related 
stigma within the military. 
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3.0 Department of Defense Policies 
3.1 HIV Screening Policies 
Department of Defense Instructions (DoDI) and Directives establishes protocols and 
outlines accountability of designates entities, which are tasked to ensure the proper 
implementation of the mandated guidelines. DoDI 6485.01, HIV in Military Service Members, is 
a discourse of screening requirements and implications associated with positive findings [30]. 
Initial HIV screening occurs during the pre-accession phase, when civilians are screened before 
appointments, enlistments and inductions [30]. Presence of HIV or serological evidence5, and 
false-positive screenings with ambiguous results on confirmatory immunological testing leads to 
rejection of military service [21]. Within 72 hours of reporting to officer candidate programs, 
applicants are screened and if laboratory evidence of HIV is discovered they are denied entry 
[30]. Candidates in the Reserve Officer Training Corps are screened during their commissioning 
physical examination and denied entry if laboratory evidence of HIV is detected [30].  
DoDI 6485.01 requires that all military personnel receive serologic HIV testing every 24 
months. Members are required to receive additional screening when tasked to deploy to 
predetermined locations for greater than 30 days. Serum collected for HIV screening must occur 
5Serologic Evidence of HIV infection is a reactive result given by a FDA approved serologic test for HIV detection. 
The U.S. military uses the standard HIV diagnostic algorithm: (1) Immunoassay (IA) initial screen (2) reactive 
specimens are duplicated using the same IA (3) Western Blot, Multispot or Geenius serologic supplemental 
confirmatory testing. Fourth-generation IA is the preferred initial screening; detection of markers of HIV infection 
begin to occur 5-7 days’ post HIV transmission. The first detectable marker is HIV ribonucleic acid followed by an 
early HIV antigen, p24 (HIV-1), then anti-HIV immunoglobulin M antibody, followed by anti-HIV IgG antibody. 20.
Okulicz, J.F., et al., Review of the U.S. military's human immunodeficiency virus program: a legacy of progress and 
a future of promise. Msmr, 2017. 24(9): p. 2-7. 31.Army Regulation 600-110 Identification, Surveillance, and 
Administration of Personnel Infected with Human Immunodeficiency Virus. 2014, Department of the Army.  
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within 120 days prior to deploying and again within 4 days of returning [32]. If seroconversion is 
detected while serving in the military, members are medically evaluated to determine the 
continuance of service [30]. Members found medically fit are allowed to continue service, in a 
capacity that is conducive to on-going treatment [30]. Members deemed unfit for duty or 
medically incapable of military service will receive medical separation [30].  
3.2 LGBT Regulations 
The first official document prohibiting homosexual conduct in the U.S. military was 
published in 1982 [22]. The guidance outlined the terms of dismissal for any service member that 
engaged in, attempted to engage in, had a propensity to engage in or intended to engage in 
homosexual acts [22, 33]. “Don’t Ask, Don’t Tell”, a directive issued in 1993, allowed 
homosexual activity and relationships among service members [34]. Conversely, members were 
still discharged from service in the event that information regarding homosexuality was obtained 
by military leadership [34]. Public Law 111–321 repealed “Don’t Ask, Don’t Tell” in 2010, 
which allowed unrestricted homosexual activity and relationships [35]. Additionally, the DoD 
established the acceptance of transgender service members and outlined protocols related to 
transitioning while actively serving in the U.S. armed forces in 2016 [25, 36].  
13 
3.3 Pre-Exposure Prophylaxis 
The Defense Health Agency released provisional guidance in 2018, which requires 
that HIV pre-exposure prophylaxis (PrEP) is accessible to all high-risk military service members 
and their dependents [23]. The memorandum mandates the designation of clinical staff and 
providers whom are culturally competent in the areas of risk related to the HIV transmission, risk 
reduction, PrEP evaluation, ongoing monitoring and adherence. A qualified PrEP provider6 must 
be available at all military treatment facilities in non-hostile locations [23]. Furthermore, the 
memorandum prohibits PrEP usage as a reason for denial of entry into the military or denial of 
reenlistment [23]. Additionally, members taking PrEP are now eligible to deploy [23]. Routine 
STI and HIV screening is mandatory for service members taking PrEP [23].  
3.4 Air Force, Army, Navy and Marine Corps Screening Policies 
Service branches and individual military installations are allowed to develop more 
stringent HIV screening policies, as long as they do not reduce or override DoD policy. Table 2 
is a compilation of supplemental policies pertaining to STI and HIV screening requirements, 
programs and reporting protocols sanctioned by the Air Force, Army, Navy and Marine Corps. 
6 “The Qualified HIV PrEP provider must have knowledge of obtaining a detailed sexual history, providing HIV risk 
reduction counseling, identifying indications for HIV PrEP, knowledge of eligibility criteria, knowledge of PrEP 
contraindications, knowledge of clinical considerations for HIV PrEP, knowledge of current guidelines for lab and 
clinical evaluation, knowledge of follow-up screening for HIV and sexually transmitted infections.” 23.Interim 
Procedures Memorandum 18-020, Guidance for the Provision of Human 
Immunodeficiency Virus (HIV) Pre-Exposure Prophylaxis (PrEP) for Persons at 
High Risk of Acquiring HIV Infection. 2018, Department of Defense, Defense Health Agency. 
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The DoD recommends that service branches follow CDC and USPSTF recommendations, which 
are outlined in Appendix 2.  
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Table 2. Active Duty Air Force, Army, Navy & Marine Corps Screening Policies 
STI Screening and Programming Supplemental HIV Policies 
Air Force 
AFI-44-178 
 STI interviews with risk reduction counseling [24]
 STI contact investigations [24]
 HIV screening is required when the following
indicators are present [31]:
— newly diagnosed tuberculosis 
— recent STI diagnosis  
— entry into drug/alcohol treatment program 
Army 
DA PAM 40-11 
AR 600-110 
 Female are required to receive annual chlamydia
screening until 25-years-of-age [19, 37]
 Community/unit health education [37]
 STI case interviews [37]
 STI contact investigations [37]
 Patient education [37]
 HIV screening is required when the following
indicators are present [31]:
— recent STI diagnosis 
— unexplained enlarged lymph nodes 
— depressed white cell count 
— depressed platelet count 
— neurological disease 
— adult oral candidiasis 
— intravenous drug use  
— evidence of an opportunistic infection 
 New members who received their accession HIV
screening more than 6 months after beginning basic
training, will receive an additional HIV screening
within 29 days of reporting to training [31]
 Sexual partners of HIV infected individuals are
required to receive additional HIV screening [31]
Navy and 
Marine 
Corps 
 Enlisted recruits receive chlamydia and gonorrhea
screening during boot camp [38, 39]
 Females are required to receive annual chlamydia
screening until 24-years-of-age [19, 38, 39]
 STI case interviews [39]
 STI contact investigations [39]
 HIV screening is required when the following
clinical indicators are present [41]:
— diagnosis of an STI  
— entry into drug or alcohol treatment 
— diagnosis of active tuberculosis 
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BUMEDINST 
6222.10C 
SECNAVINST 
5300.30F 
 Syphilis screening is performed during the following
circumstances [39]:
— following a chlamydia or gonorrhea diagnosis 
— if symptoms are noticed by a medical provider 
— if listed as a sexual contact during a STI 
interview 
 Personnel on PrEP are screened STIs semi-annually
[23, 38]
 Sexual Health and Responsibility Program7 (SHARP)
implementation [40]
 Personnel on PrEP receive quarterly HIV
screenings [23, 38]
Disease 
Reporting 
 The Disease Reporting System internet (DRSi) is the
established incidence-reporting tool for the U.S.
military which is designated to track Armed Forces
Reportable Medical Events. Chlamydia, gonorrhea
and syphilis are reportable events [4]
 Air Force: United States Air Force School of
Aerospace Medicine and Armed Forces Health
Surveillance Branch [31]
 Army: Armed Forces Health Surveillance Branch
[31]
 Navy and Marine Corps: Navy and Marine Corps
Public Health Center and Armed Forces Health
Surveillance Branch [39]
7 The Navy and Marine Corps Public Health Center has established SHARP with intent to prevent HIV, STIs and unplanned pregnancies. SHAPR’s risk reduction 
educational and training materials are available to all service branches. These materials include films, program guidelines, lectures, courses, factsheets and posters. 
Medical personnel receive specialized training in assessing sexual risk factors and developing risk reduction plans. 40. MacDonald, M.R., Sexual Health and 
Responsibility Program (SHARP): Preventing HIV, STIs, and Unplanned Pregnancies in the Navy and Marine Corps. Public Health Reports, 2013. 128: p. 81-88. 
Table 2 Continued
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4.0 Discussion 
Population specific considerations within the U.S. armed forces suggest that a significant 
proportion of the group is at an increased risk of STI acquisition. Infrequent screening amplifies 
the risk of acquiring an STI primarily due to the age demographic, reported high-risk behaviors, 
mobility and cultural influences [15, 16, 42, 43]. Additionally, current screening regulations 
present the opportunity of incessant STI circulation throughout the population [44]. One-in-five 
service members are at an increased risk of HIV and STI acquisition which is defined as in the 
past year: having more than one sexual partner, lack of condom use with a new partner, STI 
diagnosis or MSM [16]. High risk behaviors were most frequently reported among service 
members between the ages of 18-24-years-olds and lower enlisted [16]. Furthermore, a 
retrospective study reported that 36% of females and 18% males with over 20 years of service 
had at least one STI recorded between 1997-2010 [44]. 
High rates of STI acquisition have been reported during the deployment phase [44]. 
Approximately 60% of service members reported having deployed at least once during their 
military career [16]. The deployment phase is defined as the 120-day time period prior to 
departure, time spent in theatre and 3-months following the return to home station [44]. 
Psychological stress and interpersonal relationship changes, reported during the deployment 
phase, could have an influence on high rates of binge drinking, substance abuse and low rates of 
condom usage [16, 19, 42]. A study conducted by Lieutenant Colonel Aldous concluded that a 
significant amount of STIs reported during deployments could have been detected prior to the 
departure, at the member’s unit[45]. Rates of STIs diagnosed in personnel under 30 were similar 
to the U.S. population [45]. However, higher rates of STIs among older service members were 
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detected while in theater when compared to reported rates in the continental U.S. [45]. 
Nevertheless, the literature suggests the necessity of increased STI surveillance before, during 
and after deployments [42, 44, 45]. Missed screening opportunities during the deployment phase 
encourages the further spread of infections and the development of secondary conditions [45].  
DoD, Air Force, Army, Navy and Marine Corps policies, have been continuously 
progressive in reducing the transmission of HIV [12, 13]. Routine and supplemental HIV 
screening policies have likely contributed to the relatively low HIV incidence rates within the 
military as compared to the U.S. population [20]. However, 30% of service members who 
reportedly engaged in high-risk behaviors, do not receive annual screening in accordance with 
the CDC’s and USPSTF recommendations [16, 29].  Similarly to the U.S. population, MSM in 
the military are disproportionately diagnosed with HIV [20]. However, a recent policy developed 
by the DoD has aimed towards expanding PrEP accessibility and further investing in healthcare 
provider education [23]. Members that engage in high-risk behaviors can greatly benefit from the 
U.S. armed forces PrEP policies. Increasing the frequency of HIV screening could potentially 
capture early infections among high-risk groups and further reduce transmission rates.  
A study conducted by Gurung, et al., has reflected the presence of sexual orientation 
discrimination resulting from previously restrictive policies [41]. The literature also emphasizes 
the importance of medical providers receiving specialized education regarding screening and 
providing care to LGBT service members [41, 46]. Addressing stigma and enhancing medical 
providers knowledge could increase the likelihood that LGBT service members seek STI 
prevention and detection services when necessary.  
The DoD recommends that service branches implement STI screening, in accordance 
with CDC and USPSTF guidelines (see Appendix B) [26, 28]. This approach allows flexibility, 
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which may result in inadequate STI screening and surveillance among the military population. 
Additionally, the CDC and USPSTF does not support routine chlamydia or gonorrhea screening 
for men, based on their lack of sufficient evidence reflecting associated benefits [28]. The Navy 
and Marine Corps are the only service branches currently requiring both males and females to 
receive STI screening during accession [38, 39]. Furthermore, they are the only entities that 
currently have a standard screening requirement for males at any point throughout their military 
careers [38, 39]. The Army, Navy and Marine Corps requires that females receive annual 
chlamydia screening until 25-years-of-age [38, 39]. However, there is no evidence suggesting 
that the Air Force conducts mandated STI screenings. The platform in which service branches 
have, affords them the opportunity to increase surveillance efforts through policy. Although there 
are different policies in existence, standardizing protocols could be beneficial to this population. 
Cost-effectiveness associated with female STI screening is frequently mentioned 
throughout literature, and acknowledged by the DoD [19, 28, 47, 48]. Although not commonly 
recognized, cost-effectiveness has also been associated with universal STI screening among 
males [28, 49]. A statistical analysis and financial model, developed by Nevin, et al., 
demonstrated economic efficiency linked to routine chlamydia screening conducted among 
military male recruits, aged 24-years and younger  [50]. Additionally, a study evaluating STI 
screening amongst job-training program entrants, provided evidence supporting the cost-benefit 
of male and female chlamydia screening, utilizing urine-based nucleic acid amplification tests 
[49]. The previously mentioned study, also examined the relationship between cost and 
asymptomatic chlamydia infections, finding that 84% of infections were asymptomatic in 
females and 29% in males [49]. Screening males in high-risk demographics, such as the military, 
has the potential to decrease the spread of infections, and avert PID and chronic pelvic pain in 
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females [49, 50] Acknowledgment of cost-effective male and female STI screening could 
solidify justification required to standardize screening protocols within the U.S. armed forces 
policies. 
The existing STI prevention and detection strategies within the U.S. military relies on 
elective male screening. This is problematic considering the potential of asymptomatic 
infections, inaccurate incidence rates and the continued spread of infections [51, 52]. A study 
conducted by Army researchers diagnosed 4.9% of participating male recruits receiving 
obligatory screening with either gonorrhea or chlamydia [52]. However, only 0.5% of the 
infected participants reported symptoms [52]. Previous studies have demonstrated the benefits of 
routinized STI screening in male populations, such as, the detection of asymptomatic infections 
and increased surveillance accuracy [51, 53, 54]. New York City jails implemented universal 
chlamydia and gonorrhea screenings among male inmates in New York City jails [54]. 
Following the programs implementation, New York City experienced a 59% increase in reported 
chlamydia infections and a 4% increase in reported gonorrhea infections, among males [54]. 
Conversely, the transition from universal STI screening to symptom-based screening, among 
male a study cohort, was associated with a 91.7% decrease in reported chlamydia infections and 
90.5% decrease in gonorrhea infections [53]. The U.S. armed forces could benefit from routine 
screening to treat asymptomatic infections found in males and females that would otherwise go 
undetected.  
There is a gap in screening policies and available incidence rates addressing extra genital 
screening and STI rates among the U.S. armed forces. A recent study conducted by Dukers-
Muijrers et al. observed anorectal infections occurring at rate similar to genital infections, found 
in women and MSM (Table 2) [55]. While pharyngeal chlamydia infections were low, 
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pharyngeal gonorrhea infections were similar to genital infections, which occurred as a single-
site infections in 53% of MSM and 73% of women [55].  The literature suggests the extra genital 
infections are frequently asymptomatic and risk behaviors are not always indicative of anorectal 
or pharyngeal infections [25, 55]. Establishing policy that includes opting out of extra genital 
screening has the potential to capture single-site asymptomatic infections that remain undetected 
and untreated.  
Table 3. Prevalence of extra genital chlamydia and gonorrhea in 
women and MSM 
Women MSM 
Chlamydia Gonorrhea Chlamydia Gonorrhea 
Pharyngeal 1-3% 1-2% 1-3% 4-12%
Anorectal 7-17% 0-3% 1-18% 6-21%
Genital 5-13% 1-2% 3-8% 3-11%
Chart derived from Dukers-Muijrers et al. study [55] 
Due to data and reporting limitations, obtaining accurate rates of STIs within the armed 
forces is a challenge. U.S. military data limitations identified in the literature include the absence 
of standard reporting procedures; inconsistency in medical code usage; incomplete health data 
from deployed medical treatment facilities; and members failing to self-report STIs diagnosed 
from civilian medical providers [2, 18, 56]. Creating standardized STI reporting protocols could 
contribute to an accurate and comprehensive representation of STIs diagnosed within the U.S. 
military population. Furthermore, this process could provoke dialog directed towards the 
cultivation of a culture that prioritizes proactive STI detection and prevention methods. 
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5.0 Recommended Programmatic Framework 
The DoD has a unique opportunity to capitalize on existing entities within the 
organization which possess the capacity to reduce STIs within the population and strengthen 
detection efforts. Historically, the military has been supportive in public health efforts aimed at 
preventing STI infections. Studies have provided evidence supporting benefits, feasibility and 
cost-effectiveness of STI screening programs among young populations which are similar to the 
U.S. armed forces demographic [44, 49, 50, 55, 57].   
Behavioral change interventions implemented in military populations have been effective 
in reducing high-risk behavior associated with STI transmission, such as, increased knowledge of 
STI/HIV transmission and condom use [58, 59]. A study conducted by the Army demonstrated 
overall programmatic effectiveness, which consisted of detecting asymptomatic chlamydia and 
gonorrhea infections in male recruits, and increased intent to utilize condoms and confidence in 
condom usage [52].  
There is an increasing amount of reported STIs within the U.S. armed forces, which 
could be indicative of a programmatic need addressing the spread of infections. Nevertheless, 
there is no mention of force-wide universal STI screening or prevention strategies throughout the 
DoD’s policies. Beneficial and negative impacts of current policies, programs and population 
considerations are outlined in Table 4.  
Table 4. Beneficial and Negative Impacts of Current Policies 
Strengths Negative Impacts 
 Routine and supplemental HIV
screening
 STI interviews & contact screening
 Overall increase in STI incidence rates since
2014
 1/5 service members report high-risk behavior
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 Established reporting tools
 PrEP expansion & medical provider
education
 DoN: male and female accession STI
screening
 DoN & Army: routine chlamydia
screening for females under 25-years-
old
 Male and female STI screening is cost
effective
 Asymptomatic infections can be
detected through routine STI screening
 Population contains 50%, 18-24 year-olds,
who are in a “high risk” age demographic
 Overall missed STI screening opportunities
during accession, deployment and routinely
 Lack of standardized screening and
educational policies between branches
 Infrequent gonorrhea screening among
females
 Overall lack of male STI screening
 Unclear reporting procedures
 Previously restrictive policies contributing to
stigma
 Undetected asymptomatic STIs
 No indication of extra genital infection
incidence data
 30% of high risk individuals do not report
annual HIV screening
To address deficiencies, a pilot program imposing screening and prevention strategies has 
been developed that is outlined within the Logic Model located in Table 5. The impacts the 
developed strategies are intended to provide an understanding of benefits related to the 
standardization of prevention and detection measures. The long-term goal of the pilot’s 
framework is to cultivate a culture in which proactive STI prevention and detection strategies are 
normalized within the U.S. armed forces and their policies.  
Table 4 Continued
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Table 5. Logic Model 
Inputs 
Outputs Outcomes 
Medium
Long
Activities Participants Short Medium Long 
 Established leadership
with the authorization
to implement
mandatory screening
 Proficient medical and
public health personnel
 Office/clinical space
 Established accession
and deployment
medical processing
 Disease Reporting
System internet (DRSi)
 Partnership with the
RAND Corporation
 Subject matter experts
at the NMCPH
 Developed STI
prevention trainings
(SHARP)
 Standardized STI
screening
 Opt-out and self-
administered extra
genital screening
 SHARP Training
Development
 Training
implementation (Peer
Educators, Risk
Reduction Experts, STI
Program Managers,
medical personnel)
 Installation sexual
health promotion events
 All males and females
during accession
 Male and female service
members 18 to 24-year-
old
 Deployers
 General population at
navy installations
 Designated peer-
educators, risk reduction
experts and STI program
managers
 Medical personnel
 100% of designated
entry points screen
accessed members for
STIs by year 2
 100% of deployers are
screened for STIs prior
to deployment by year 2
 100% of medical
personnel have
completed designated
online training by year 2
 80% of all installations
have trained program
implementers by year 3
(Peer Educators, Risk
Reduction Experts, STI
Program Managers)
 80% of personnel have
attended at least one
peer-education session
annually by year 3
 Increased detection of
STIs
 Increased understanding
of STI infections among
members
 20% increase in elective
STI screening by year 3
 40% self-efficacy
increase in members
that received peer
education (regarding
intention to engage in
healthy behaviors and
seek necessary health
care)
 15% decrease in
reported high-risk
behaviors reflected by
year 4
 50% decrease in stigma
associated with STIs
and screening by year 5
 Effective policy
developed and enforced
throughout the U.S.
armed forces
 Culture of normalized
proactive STI detection
strategies
Assumptions/Theoretical Constructs: 
Understanding the true burden of infections will provide evidence supporting the
development effective prevention and detection policy
Routinized screening will normalize STI testing and reduce associated stigma.
Increased provider knowledge will increase provider patient dialog.
Peer-education will raise levels of self-efficacy of reducing risk and seeking
screening with necessary.
Overall STI programming will provide risk reduction tools and normalize
prevention, which will increase healthy behaviors, such, elective screening and risk
reduction counseling (Information-Motivation-Behavior Skills Model [60])
Training peer education will create the opportunity for service members to feel
comfortable discussing risk behaviors and strategizing plans to reduce risk in an
everyday environment.
External Factors: 
Medical processing presently occurs during accession and within the deployment
phase. Cost-effecting mandatory screening will occur seamlessly.
Standardizing STI screening within 18 to 24-year-old will occur during birth
months, which will create a routine with the potential to continue beyond the age
of 25.
The established partnership with the RAND Corporation will allow for
convenient and budget-friendly evaluations.
Hesitation could surface from leadership regarding the cost associated with
standardized screening.
As the military is not a closed population, rates of STIs among members will be
affected by national trends, which the DOD has no control over.
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5.1 Implementation Strategy 
The mobile nature of military personnel associated with frequent reassignment of duty 
stations, deployments and discharge from service, presents major issues in assigning cohorts to 
the interventions and their comparative groups [40]. Therefore, to off-set turnover, the 
intervention pilot will consist of an entire service branch, as opposed to an assigned cohort of 
specified individuals or installations. For the purpose of this essay, the proposed approach would 
be Navy pilot implementation. Selection was based on the high level of subject matter expertise 
regarding STI prevention programming at the Navy and Marine Corps Public Health Center. For 
evaluation purposes, the remaining branches will serve as the comparison groups.  The pilot 
initiatives will remain in place for a duration of 5-years. Following evaluation, medical 
leadership from all branches will gather to review the effectiveness of protocols. As outline in 
Figure 9, following evaluation, development of a DoD instruction will occur. The policy will 
mandate force-wide protocols, which aims to develop a culture that emphasizes the importance 
of proactive STI prevention.  
Figure 9 Implementation and Program Strategy 
Navy Pilot 
Implementation
Evaluation 
DOD STI Policy 
Development & 
Implementation 
Culture Change: 
Proactive STI prevention 
& detection
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5.2 Theory: Information-Motivation-Behavioral Skills Model 
Information-Motivation-Behavioral Skills Model applies a three-dimensional structure, 
focusing on separate constructs with an intersecting pathway leading to behavior change [60]. 
Designated Navy personnel will receive risk reduction education, routinized STI screening and 
activities aimed towards reducing social and cultural stigma related to STI screening and 
prevention. It is hypothesized that such an intervention will lead to reduced STI incidence rates, 
normalization of STI screening, increased levels of risk-reduction knowledge and reduced high-
risk behaviors. 
5.3 Programmatic Framework 
The programmatic framework outlined in Table 6, are recommended requirements in 
which the pilot program will impose. The protocols are intended to provide the understanding of 
impacts associated with routinized STI screening and prevention programming within the U.S. 
Navy.  
Table 6. U.S. Navy Pilot Program Requirements 
HIV Screening Annual HIV screening will occur on an annual basis for all personnel. 
Accession 
All new members will receive urine-based chlamydia and gonorrhea 
screening within 30 days of all routes of accession, which includes basic 
training sites, officer training schools and commissioning physicals. 
Deployment 
In alignment with HIV screening, urine-based chlamydia and gonorrhea 
screening will occur for all deploying members. 
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Annual Screening 
Annual urine-based chlamydia and gonorrhea screening will occur for all 
members under 25-years-of-age. Screening will occur during the members 
birth month. 
Follow-up 
All members who have a positive chlamydia or gonorrhea screening will 
require syphilis testing. 
Opt-out Extra 
genital 
During all elective and required STI screening encounters, members will be 
prompted with self-administered, opt-out pharyngeal and anorectal 
screening. 
Annual Health 
Education 
Unit level peer-led sexual health education, which will occur in a group 
setting. All members will be required to attend at least one session, per 
calendar year.  
Medical Personnel 
Education 
All medical personnel will receive annual training, which will consist of 
STI prevention strategies, screening and reporting requirements.  
Installation Health 
Promotion 
All installation must host at least two sexual health promotion events each 
calendar year 
Reporting 
All healthcare providers on military installations, ships and deployed sites 
must report all diagnosed and self-reported STIs, location of infection site 
and presence of symptoms into the Disease Reporting System internet. 
Recommended roles and responsibilities described within Table 7, are designated to 
ensure the compliance of pilot implementation, evaluation and expansion. The expansion 
strategy and evaluation roles are discussed in a later section within this essay. 
Table 7. Program Roles and Responsibilities 
Armed Forces 
Health 
Surveillance 
Branch, 
Public Health 
Office 
The Public Health Office will: 
 Ensure that program evaluation materials are presented to Air Force,
Army and DoN Surgeon General Offices.
 Ensure the development of an evidence-based DoD policy addressing the
standardization of prevention and detection strategies.
Navy and 
Marine Corps 
Public Health 
Center- 
SHARP office 
The SHARP office will: 
 Serve at the pilot program headquarters.
 Ensure evaluation components are complete.
 Provide program support to installations.
 Ensure program trainings and materials are developed and modified in
accordance with programmatic guidelines.
Installation 
Commander 
Installation Commanders will ensure that their respective installation complies 
with program guidelines. 
Table 6 Continued
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Medical 
Treatment 
Facility 
Commander 
Medical Treatment Facility Commanders will: 
 Ensure that medical personnel are aware of mandated screening and
reporting requirements.
 Ensure that adequate supplies are available to perform screenings.
 Assign the role of the installations STI Program Manager to a service
member attached to Preventative Medicine or Public Health.
 Report compliance to Installation Commander.
STI Program 
Manager 
STI Program Managers will: 
 Provide program oversight at the installation level.
 Serve as liaison between program headquarters and respective location.
 Ensure evaluations are collected and provided to headquarters.
 Serve as the installations subject matter expert in proper DRSi reporting
and provide technical assistance.
 Ensure that E1-E5 service members fulfill the (2) roles of Risk Reduction
Experts, with at least one member from Preventative Medicine and one
from Public Health.
 Communicate with MTF Commander and Medical Personnel Leadership
annual and screening and medical personnel training requirements
Risk 
Reduction 
Expert 
Risk Reduction Experts will: 
 Serve as STI subject-matter experts for respective location.
 Host at least two health promotion events focused on risk reduction
 Ensure that each work area has an assigned peer-educator and conduct
associated training.
 Provide one-on-one risk reduction counseling as requested.
 Modify peer-education presentation materials.
Peer Educator 
Peer Educators will: 
 Conduct semi-annual peer education in respective work areas
 Conduct peer education on an as needed basis
Medical 
Personnel 
Leadership 
Medical Personnel Leadership will: 
 Ensure appropriate personnel have completed annual training.
 Provide STI detection training, assistance or resources when appropriate.
 Ensure that all positive screenings and associated characteristics are
reported to the STI Program Manager weekly.
Unit Health 
Monitor 
Unit Health Monitors will: 
 Ensure that respective unit members are aware of upcoming screening
requirements on a rolling basis.
 Notify unit leadership if members are past due on screening
requirements.
Table 7 Continued
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5.4 Training Development and Implementation 
Within this recommended framework, the Navy and Marine Corps Public Health Center’s 
(NMCPHC), Sexual Health and Responsibility Program (SHARP) office is primarily responsible 
for training development. SHARP has established trainings that will receive modification or 
guide the development of training implicated within this intervention. Table 8 summaries 
designated roles of trainings that will occur during the pilot program. 
Table 8. Training Implementation Roles 
SHARP 
 Initial STI Program Training (in person) Trainer
 STI Program Refresher Course (online) Trainer
 STI Program Training for Medical Personnel
(online)Trainer
 HIV PrEP Lecture (online) Trainer
STI Program 
Manager 
 Initial STI Program Training Trainee
 STI Program Refresher Course annually Trainee
 Peer Education Training Trainer (if, Risk Reduction
Experts are not available
Risk Reduction 
Expert 
 STI Program Training Trainee
 STI Program Refresher Course annually Trainee
 Education Training Trainer
Peer Educator 
 Peer Education Training Trainee
 Annual (unit-level) Peer Education Trainer
Medical Personnel 
 Annual STI Program Training for Medical Personnel
Trainee
 HIV PrEP Lecture Trainee
STI Program Training: The SHARP office will develop and implement STI Program Training. 
This training will serve as the initial guidance for STI Program Managers and Risk Reduction 
Experts. STI Program Training is intended to prepare participants to train peer educators, train 
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medical personnel, provide risk reduction counseling, promote sexual health and provide 
programmatic support. The training will consist of a condensed version of previously developed 
NMCPHC-SHARP tools, listed in Table 9. The training for all new implementers will take place 
at the NMCPHC, over the course of five days. NMCPHC will provide attendees with preparation 
materials, which will assistance in proficiently providing training at respective installations. 
Table 9. Previously developed STI trainings, SHARP8 
STI Basics for Non-
Clinicians (4 hours)9 
Increases basic knowledge of sexually transmitted infections 
Promoting Sexual 
Health in Military 
Populations (4 hours)10 
Provides skills required to plan and execute effective community 
strategies to reduce sexual risk behavior within military 
communities.  
HIV-STI Prevention 
Counseling Course (8-
16 hours)11 
Improves the ability of healthcare providers (doctors, physicians 
assistants, nurses, medical technicians, etc.) in a variety of settings, 
to support individuals in making behavioral changes that will reduce 
their risk of acquiring or transmitting HIV or other STIs.  
HIV PrEP Lecture (1 
hour)12 
Familiarizes health care providers and health care support 
professionals with the HIV prevention strategy of PrEP. Participants 
learn the basics of HIV PrEP, HIV risk profiles, patient eligibility 
for PrEP, patient management, operational and clinical challenges 
and HIV PrEP promotion 
8 A full listing of SHARP trainings offered by the Navy and Marine Corps Training Center can be located using the 
following link: https://www.med.navy.mil/sites/nmcphc/health-promotion/training/Pages/SHARP.aspx 
9  STI Basics for Non-Clinicians program information: https://www.med.navy.mil/sites/nmcphc/Documents/health-
promotion-wellness/reproductive-and-sexual-health/sti_101_info.pdf 
10 Promoting Sexual Health in Military Populations program information: 
https://www.med.navy.mil/sites/nmcphc/Documents/health-promotion-wellness/reproductive-and-sexual-
health/promotesexhealthinfo.pdf 
11 HIV-STI Prevention Counseling Course program information:  
https://www.med.navy.mil/sites/nmcphc/Documents/health-promotion-wellness/reproductive-and-sexual-
health/ccinfo3.pdf 
12 HIV PrEP Lecture program information: https://www.med.navy.mil/sites/nmcphc/Documents/health-promotion-
wellness/reproductive-and-sexual-health/sharp-hiv-prep-info.pdf 
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STI Program Refresher Course: The SHARP office will develop an annual computer-
based training (CBT), which emphasizes competencies learned during the initial STI Program 
Training. Additionally, the training will cover new findings, and updated best practices and 
program protocols (if appropriate).  
Peer Education: The SHARP office will develop a peer education-training tool, consisting of a 
condensed version of the STI Basics course and Promoting Sexual Health in Military 
Populations. They will also develop peer-education facilitation materials. Risk Reduction 
Experts will update the provided peer-education presentation template annually, which is to 
include installation specific concerns. 
STI Program Training for Medical Personnel: The SHARP office will develop a CBT for 
medical personnel, which will cover screening requirements, basic risk reduction information 
and components of STIs that are required for reporting within the DRSi,. 
5.5 Evaluation Outline 
The results of the pilot program evaluation will heavily influence the expansion plan, 
which will guide policy development. Therefore, formative, process, outcome, and impact 
evaluations of the prospective program components will occur, which are summarized in Table 
10. Installations will complete detailed annual reports covering designated evaluation
components and send results to the SHARP office. The SHARP office will complete designated 
internal elevations. A detailed compilation of all evaluation components will be complied by the 
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SHARP Office and received by the Armed Forces Health Surveillance Branch. The final report 
will guide policy development. 
Table 10. Evaluation Components 
Surveillance  DRSi- screening encounters (process)
 DRSi- provided STI information (process)
 Opt-out screening (process)
 Program training (process)
 Elective screening (outcome)
 Characteristics of STIs (outcome)
 STI incidence rates (impact)
Training  STI Program Training (process)
 Peer Education Training (process)
 Peer Education (process)
 Health Promotion events (process)
Culture/Behavior  Behavior impacts (outcome)
 Climate survey (impact)
 Program Feedback (formative)
 Selective forum (formative)
Process Evaluation: 
 Screening Encounters: Screening Encounters: Tracking the compliance of screening
requirements promote maximum program reach. The statuses of medical requirements
are tracked, in real-time, through the Medical Readiness Reporting System (MRRS)13.
The screening and educational components outlined within the presented framework will
be integrated into the MRRS. Medical personnel will update the member’s record to
13 MRRS is the Navy, Marine Corps and Coast Guard’s tool designed to record and track Individual Medical Readiness 
(IMR) elements to include immunizations, dental status, laboratory tests, and physical exams such as periodic health 
assessments, deployment health status, pregnancies, illnesses, and injuries. MRRS is a web-based, real-time 
application with a central aggregating database, which links with existing authoritative data systems for personnel 
tracking including the Navy Standard Integrated Personnel System (NSIPS) and Marine Corps Total Force System 
(MCTFS). MRRS gives headquarters staffs and leadership a real-time view of Force Medical Readiness and 
immunization status. https://www.health.mil/Military-Health-Topics/Health-Readiness/Immunization-
Healthcare/Immunization-Tracking-Systems 
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indicate completion after screening is accomplished. Risk Reduction Experts will enter 
the completion of annual peer education sessions with MRRS. STI Program Managers 
(SPMs) will track the installations monthly compliance, and include these figures in the 
annual report, which is sent to the SHARP office. Additionally, SPMs will address 
compliance concerns with the Medical Treatment Facility Commander. Multi-level 
management of compliance will increase the likelihood that the pilot is conducted its 
intended manner.  
 Opt-out Screening: The purpose of this evaluation measure it to assess the offering of
opt-out screening by medical personal. While entering screening encounters within
MRRS, personnel will indicate if opt-out screening was presented. The SPM will track
monthly compliance of opt-out screening and address concerns with the Medical
Treatment Facility Commander.
 Program Training: The SHARP office will create an online spreadsheet, incorporating a
listing of current Risk Reduction Experts (RREs) and SMPs, and their respective training
status. The final report will include this figure, which highlights the reach of program
training.
 Peer Education Training: To capture the number of members who were trained as Peer
Educators, RREs, at each installation, will annually report the participant count to the
SHARP office.
 Peer Education Sessions: During peer education sessions, the facilitator will capture
attendance. SPMs will annually report the number of individuals, to capture the reach of
the peer education component.
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 DRSi: Weekly, SPMs will confirm STI incidence data accuracy. SPMs will address
concerns regarding inaccurate data to the Medical Treatment Facility Commander.
Additionally, SPMs will annually provide a count of incomplete reports the SHARP
office.
Outcome Evaluation 
 Elective Screening: This measure is intended to evaluate the impact of programming on
elective screening encounters. Elective and mandatory screening encounters are recorded
within the MRRS. Medical personnel will indicate the type of screening (mandatory or
elective) and screening site (anorectal, penile, pharyngeal or vaginal). The MRRS Report
Menu will include annual counts of STI screening encounters and supplementary
information. The SHARP office will compile and analyze data for presentation in the
annual report.
 Characteristics of infections: As an effort to understand the characteristic of infections
that occur with the population, DRSi will receive an update prior to program
implementation. This update will include the addition of STI incidence information (see
below). Weekly, medical providers will gather STI incidence information and provide it
to the SPM. The SPM is responsible for entering STI occurrences into DRSi.
 absence or presence of symptoms
 type of screening: mandatory, elective or opt-out
 infection site: anorectal, penile, pharyngeal or vaginal
 concurrent infection detected: yes or no; if yes, site of concurrent infection
 Behavior Measure: The RAND Corporation conducts the randomized Military Health
Behaviors Survey every three years. The program office will use the 2018 dataset as
baseline information and compare the findings to the data obtained through the 2021 and
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2024 surveys. The areas of focus will include sexual behaviors and level of comfort 
seeking health care services. 
Impact Evaluation 
 STI incidence rates: An increase of reported STIs are expected, due to the increased
surveillance and education strategies. The SHARP office will request DRSi incidence
data from the Armed Forces Surveillance Branch. SHARP will evaluate STI incidence
rates and the characteristic of infections prior to and during program implementation.
Further evaluation will include a comparison of rates between the Navy and other service
branches. This measure is intended to evaluate the impact of routinized screening and
serve as a guide to implement future policies. The overall areas of concerns include the
rate of asymptomatic infections, impact on STI detection frequency, and single-site or
concurrent extra genital infections.
 Climate Survey: Under the direction of SHARP, the RAND Corporation will develop and
evaluate a climate survey. The purpose of the survey is to understand the levels of stigma
related to STI prevention and detection services. This survey will undergo randomized
distribution to members of all service branches, with the intention to measure possible
differences among the Navy and other branches. The specification on an evaluation tool
is beyond the scope of this essay.
Formative Evaluation 
 Program Feedback: The SHARP office will elicit program feedback from Navy
personnel. SHARP personnel will create a compilation of feedback, listed in the annual
reports and presented during the policy development process.
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 Policy Development: Formative evaluation will primarily occur through the
Interprofessional Advisory Committee. Committee members will offer feedback and
analyze the annual report to guide the policy development process.
5.6 Expansion Strategy 
Expansion of the program and finalized DOD policy development should occur within 
one calendar year upon completion of the 5-year pilot program. Figure 10 represents the 
recommended offices of programmatic responsibility and implementation rollout. In the 
expansion plan, the Armed Forces Health Surveillance Branches- Public Health Division will 
create a STI Prevention Office. The STI Prevention Office will manage the overall program and 
establish an Interprofessional Advisory Committee. The committee will incorporate designated 
members of varying ranks within appropriate occupational specialties. The Interprofessional 
Advisory Committee a will serve as counsel to the STI Prevention Office and contribute to 
policy building process. The Air Force, Army, Navy and Marine Corps public health entity will 
report to the STI Prevention Office.  Additionally, program directors will provide overall branch 
oversight and ensure uniformity of program execution. 
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Figure 10. STI Prevention Office Organizational Chart 
*denotes proposed new entities accompanying the expansion plan
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6.0 Limitations 
Governmental officials have the capacity to produce, modify or terminate policy at any 
given time. The memorandums and policies reviewed within this essay were gathered between 
January-February 2019. Items that were not published on military doctrine websites, within the 
aforementioned timeframe, were not included. The changeable nature of policies, presents 
limitations regarding currency of items reviewed within this essay. Furthermore, the enforcement 
and compliancy levels of mandated screening and educational items included within the policy 
review of this essay are unknown. Additionally, due to lack of access, it is undetermined if 
individual installations impose supplemental guidelines, requiring STI screenings or prevention 
programs. 
Screening protocols, which had conflicts between policies and key informant interviews, 
were not included in the compilation of screening and programming items. This process 
potentially limited the full scope of understanding pertaining to measures being taken to prevent 
and detect STIs by the military. For example, Air Force screening protocols were identified 
during the literature search, which included chlamydia screening for females, during basic 
training and annually if under 25-years-of-age [19]. However, the identified measures were not 
located within policy and could not be confirmed by Air Force medical personnel [24]. 
A request, for military STI incidence rates and characteristics of infections, was 
submitted to the Armed Forces Health Surveillance Branch. The request was not fulfilled; 
alternatively, the use of incidence data contained in a recent epidemiological study published in 
the Medical Surveillance Monthly Report was encouraged [2]. The available military incidence 
data, presented limitations within the scope of this essay. STI reporting tool modifications, 
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proposed in the presented programmatic framework, are based on the assumption of limited 
reporting capabilities. Incomplete descriptions of STIs within available military incidence data 
and lack of access to the reporting tool, limited the understanding of reporting and screening 
capabilities. Such as, sites of infection, simultaneous infections and the rates of asymptomatic 
infections. 
Throughout available DoD documents, explicit insight pertaining to the selection method 
of current STI screening strategies was not provided. Therefore, the discussion within this essay 
focuses on public health implications of current policies, and providing evidence to support 
additional screening. The unidentified explanation of current policies, limits the ability to 
concisely discuss the selection protocols and compile resolutions in which support the 
standardization of STI screening and education. 
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7.0 Conclusion 
This essay has (1) assessed current screening policies and their possible impacts towards 
the STI prevalence in the military, (2) discussed specific characteristics and issues of the military 
population potentially contributing to the spread of STIs and (3) presented an STI reduction 
intervention guideline. To accomplish a decrease in STI and HIV transmission within the U.S. 
armed forces, Figure 11 outlines recommended universal screening frequencies. 
Figure 11. Minimum Standardized Screening Recommendations 
Since 2013, there has been a steady increase in reported STIs in the continental U.S. and 
armed forces. The implementation of policies requiring designated STI screenings should occur in 
response to the high-risk age demographic, behavioral concerns and observed rates of infections 
within the military. Consistently detecting and treating previously undetected STIs will benefit 
Minimum Screening 
Policy 
Recommendations 
Annual HIV Screening
Annual chlamydia and 
gonorrhea screening 
for all members under 
25-years-old
Chlamydia & 
gonorrhea screening 
within 30 days of 
accession
Self-administered, opt-
out extra genital 
screening during all 
STI screening 
encounters
Chlamydia & 
gonorrhea screening 
during the deployment 
phase 
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military personnel and the surrounding community through decreasing of the overall transmission 
risks. Creating screening opportunities during initial training will further instill fitness standards 
and disrupt asymptomatic STIs that would have otherwise been undetected. In the event of STI 
acquisition during the deployment phase, presenting an immediate detection and treatment 
opportunity offers protection to service members, their families and surrounding communities. 
The educational component of the recommended framework concentrates on increased 
base-wide promotion of sexual health, peer-led educational sessions and increased provider-patient 
dialog. The educational strategies are to intended to (1) increase service members likelihood of 
identifying high-risk behaviors, (2) equip service members with necessary tools to reduce risk of 
infection and (3) increase the likelihood of members seeking preventative and screening services 
when necessary. Furthermore, stigma and risk reduction programming have the potential to 
improve the cultural experience at military installations, allowing members to feel more 
comfortable discussing their risks with a medical provider and receiving appropriate support. 
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Figure 12. Educational Strategy Objectives 
Military personnel are accustomed to an environment defined by structured leadership, 
which includes specific and delegated medical and training requirements. By improving upon 
previously established requirements, the execution of inclusive prevention and screening strategies 
have the potential to cost-effectively detect STIs at a higher frequency, and reduce the incidence 
of infections within the U.S. armed forces. 
Health Promotion 
Events
Decrease Stigma 
& Increase 
Knowledge
Peer Education
Increase 
Knowledge & 
Decrease Stigma
STI Program
Decrease Stigma 
& Promtly Treat 
STIs
Increased 
Provider 
Knowledge
Increase Patient 
Dialog 
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Appendix A Supplementary Figures
U.S. Armed Forces and U.S. Populace STI incidence distribution, by age 
Figure 13 Chlamydia incidence rates, U.S. 
(2007-2016: by age, sex) 
Graph obtained from CDC14 
Figure 14 Chlamydia incidence rates, military 
(2007-2016: by age) 
Data within graph derived from 
Stahlman and Oetting, 201715 
Figure 15 Gonorrhea incidence rates, U.S. 
(2007-2016: by age, sex) 
Graph obtained from CDC14 
Figure 16 Gonorrhea incidence rates, military 
(2007-2016: by age) 
Data within graph derived from 
Stahlman and Oetting, 201715 
14 Graphs containing U.S. incidence rates obtained from 17.Sexually Transmitted Disease Surveillance 2017. 2018, 
Centers for Disease Control and Prevention, Division of STD Prevention. 
15 Data in graphs containing military incidence rates derived from 18.Stahlman, S. and A.A. Oetting, Sexually 
transmitted infections, active component, U.S. Armed Forces, 2007-2016. Msmr, 2017. 24(9): p. 15-22. 
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Figure 17 Syphilis incidence rates, U.S. 
(2007-2016: by age, sex)     
Graph obtained from CDC16 
Figure 18 Syphilis incidence rates, military 
(2007-2016: by age) 
Data within graph derived from 
Stahlman and Oetting, 201717 
16 Graphs containing U.S. incidence rates obtained from 17.Sexually Transmitted Disease Surveillance 2017. 2018, 
Centers for Disease Control and Prevention, Division of STD Prevention. 
17 17 Data in graphs containing military incidence rates derived from 18. Stahlman, S. and A.A. Oetting, Sexually 
transmitted infections, active component, U.S. Armed Forces, 2007-2016. Msmr, 2017. 24(9): p. 15-22. 
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Appendix B Supplementary Table 
CDC18 and USPSTF19 STI Screening Recommendations 
Table 11. CDC and USPSTF STI Screening Recommendations 
Chlamydia 
& 
Gonorrhea 
 All sexually active females 24-years-of-age and younger should receive annual
screening
 All sexually active females over 25-years-old at an increased risk of infection
should receive annual screening
 Pregnant females 24-years-of-age and younger should receive screening
regardless of risk
 Pregnant females over 25-years-old at an increased risk of infection should
receive screening
 All sexually active MSM who are at an increased risk of infection should receive
screening at sexual contact sites on an annual basis or every 3-6 months.
 (Chlamydia only) Males in high prevalence areas should receive consideration
for screening
Syphilis 
 During pregnancy, females should receive syphilis testing at least once
 MSM at an increased risk of infection should receive syphilis testing annually or
every 3-6 months
 All asymptomatic individuals who are at an increased risk of infection should
receive screening
HIV 
 All individuals between 13 and 64-years-of-age should receive an HIV screening
at least once in their lifetime
 Sexually active MSM should receive screening on an annual basis if their sexual
partners’ HIV status is unknown or if they have more than one sex partner since
their most recent HIV screening
 Individuals with the following indicators should receive HIV screening:
— More than one sexual partner since last screening
— Recent STI diagnosis
— Injection drug use
— Hepatitis or tuberculosis diagnosis
— Sexual intercourse with a partner diagnosed with HIV
— Anonymous sexual partner(s)
— Sexual intercourse in exchange for money or drugs
18 CDC recommendations obtained from 29.2015 Sexually Transmitted Diseases Treatment Guidelines. 2015 June 4, 
2015; Available from: https://www.cdc.gov/std/tg2015/screening-recommendations.htm. 
19 USPHTF recommendations obtained from 28.LeFevre, M.L., Screening for Chlamydia and Gonorrhea: U.S. 
Preventive Services Task Force Recommendation StatementScreening for Chlamydia and Gonorrhea. Annals of 
Internal Medicine, 2014. 161(12): p. 902-910. 
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